These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. II: CAR-T cell therapy for patients with CD19+ acute lymphoblastic leukemia. Seber A; de CastroJunior CG; Kerbauy LN; Hirayama AV; Bonfim C; Fernandes JF; Souza M; Schafell R; Nabhan S; Loggetto SR; Simões BP; Rocha V; de Lima M; Guerino-Cunha RL; Bittencourt H Hematol Transfus Cell Ther; 2021 Nov; 43 Suppl 2(Suppl 2):S13-S21. PubMed ID: 34794791 [TBL] [Abstract][Full Text] [Related]
3. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. VIII: CAR-T cells: preclinical development - Safety and efficacy evaluation. Picanço-Castro V; Bonamino MH; Ramos RN; Guerino-Cunha RL; Oliveira TGM; Rego EM Hematol Transfus Cell Ther; 2021 Nov; 43 Suppl 2(Suppl 2):S54-S63. PubMed ID: 34794798 [TBL] [Abstract][Full Text] [Related]
4. Associação Brasileira de Hematologia, Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. Review article: Cell therapy in solid tumors. Nardo M; Motta TC; Colli LM; Avanzi MP Hematol Transfus Cell Ther; 2021 Nov; 43 Suppl 2(Suppl 2):S78-S83. PubMed ID: 34794801 [TBL] [Abstract][Full Text] [Related]
5. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. Special article: compassionate use and clinical trial on CAR-T cells. De Santis GC Hematol Transfus Cell Ther; 2021 Nov; 43 Suppl 2(Suppl 2):S64-S67. PubMed ID: 34794799 [TBL] [Abstract][Full Text] [Related]
6. European Group for Blood and Marrow Transplantation Centers with FACT-JACIE Accreditation Have Significantly Better Compliance with Related Donor Care Standards. Anthias C; O'Donnell PV; Kiefer DM; Yared J; Norkin M; Anderlini P; Savani BN; Diaz MA; Bitan M; Halter JP; Logan BR; Switzer GE; Pulsipher MA; Confer DL; Shaw BE Biol Blood Marrow Transplant; 2016 Mar; 22(3):514-9. PubMed ID: 26597079 [TBL] [Abstract][Full Text] [Related]
7. Voluntary accreditation of cellular therapies: Foundation for the Accreditation of Cellular Therapy (FACT). Warkentin PI; Cytotherapy; 2003; 5(4):299-305. PubMed ID: 12944235 [TBL] [Abstract][Full Text] [Related]
9. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. III: anti-CD19 CAR-T cell therapy for patients with non-Hodgkin lymphoma. Alencar AJ; Hirayama AV; Clé DV; Salvino MA; Perini G; Arrais C; Baiocchi O; Palma LC; Colturato I; Vaz J; Chiattone R; de Lima M; Filho JS; Nabhan S; Rocha V; Guerino-Cunha RL; Chiattone CS Hematol Transfus Cell Ther; 2021 Nov; 43 Suppl 2(Suppl 2):S22-S29. PubMed ID: 34794792 [TBL] [Abstract][Full Text] [Related]
10. Implementation of JACIE accreditation results in the establishment of new indicators that unevenly monitor processes contributing to the delivery of hematopoietic SCT. Caunday O; Agulles O; McGrath E; Empereur F; Stoltz JF; Chabannon C Bone Marrow Transplant; 2013 Apr; 48(4):604-9. PubMed ID: 23528642 [TBL] [Abstract][Full Text] [Related]
11. Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2012. Hungria VT; Crusoe EQ; Quero AA; Sampaio M; Maiolino A; Bernardo WM Rev Bras Hematol Hemoter; 2013; 35(3):201-17. PubMed ID: 23904813 [No Abstract] [Full Text] [Related]
12. Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2022. Part I. Maiolino A; Crusoé EQ; Martinez GA; Braga WMT; de Farias DLC; Bittencourt RI; Neto JVP; Ribeiro GN; Bernardo WM; Tristão L; Magalhaes RJP; Hungria VTM Hematol Transfus Cell Ther; 2022; 44(3):410-418. PubMed ID: 35970751 [No Abstract] [Full Text] [Related]